Seeking Alpha·Jun 18, 2026
Cypherpunk Technologies Inc. (CYPH) Shareholder/Analyst Call Prepared Remarks TranscriptCypherpunk Technologies Inc. (CYPH) Shareholder/Analyst Call Prepared Remarks Transcript
Cypherpunk Technologies Inc.(CYPH)Earnings, Financials & Key Ratios
CYPH•NASDAQ
$0.64
9.3× P/E·Price updated Jun 30, 2026
AboutCypherpunk Technologies Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead clinical stage drug candidate includes DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in various ongoing clinical trials for treating esophagogastric and gynecologic cancers, and colorectal cancer. The company also develops FL-501, a monoclonal antibody that inhibits GDF-15 protein that is in preclinical trial. It has an option and license agreement with Adimab, LLC and BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as Leap Therapeutics, Inc. and changed its name to Cypherpunk Technologies Inc. in November 2025. The company was incorporated in 2011 and is based in Cambridge, Massachusetts.Show more
- Revenue$0
- EBITDA-$37M+47.8%
- Net Income$5M+107.1%
- EPS (Diluted)0.07+103.8%
- ROE5.11%+103.6%
CYPH Price & Volume
Cypherpunk Technologies Inc. (CYPH) stock price & volume — 10-year historical chart
Loading chart...
Persistent Cash Burn Threatens Future Operational Viability
Investment Thesis • Updated 2026Q1
VerdictNegative
Growth:Contracting
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Imminent capital structure dilution
Key Thesis Takeaways
- Cypherpunk Technologies faces a precarious outlook as it transitions into a speculative development phase characterized by a total absence of revenue since 2024Q4.
- The company's reliance on heavy R&D spending, which peaked at $17.9 million in 2024Q2, combined with a rapidly eroding asset base, suggests significant long-term solvency risks.
- Investors should monitor the company's ability to secure additional financing, as current cash reserves have dwindled to just $6.7 million as of 2026Q1.
Verdict Logic
the company's cash runway has declined to $6.7 million as of 2026Q1, signaling an urgent and likely dilutive need for external capital to sustain its R&D-heavy business model.
CYPH Growth Metrics
Cypherpunk Technologies Inc. (CYPH) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-100%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM39.4%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM98.82%
Return on Capital
10 Years-90.07%
5 Years-90.56%
3 Years-112.05%
Last Year-37.73%
Latest CYPH News
Recent stock market news and headlines for Cypherpunk Technologies Inc. (CYPH)
Peers Comparison
Key metrics vs top competitors for Cypherpunk Technologies Inc. (CYPH)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.64 | $35.97M | 9.31 | — | — | 5.11% | — | |
| $92.68 | $30.95B | -6.09 | 2.97% | -2519.39% | -24.09% | — | |
| $1.83 | $595.92M | -5.90 | -30.65% | -146.01% | -0.11% | — | |
| $151.65 | $39.95B | 34.08 | 9.4% | 13.78% | 5.68% | — | |
| $101.83 | $91.73B | 49.67 | 51.58% | 41.12% | 21.38% | — | |
| $30.18 | $1.76B | -15.40 | 15.42% | -72.9% | -23.95% | — |
Compare CYPH vs Peers
Cypherpunk Technologies Inc. (CYPH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
CYPH SEC Filings & Documents
Cypherpunk Technologies Inc. (CYPH) SEC filings — annual & quarterly reports (10-K, 10-Q)
8-K Announcements
6Material company update
May 26, 2026·SEC
Material company update
May 14, 2026·SEC
Material company update
Apr 10, 2026·SEC
10-K Annual Reports
310-Q Quarterly Reports
6Get notified when CYPH posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
CYPH Frequently Asked Questions
Cypherpunk Technologies Inc. (CYPH) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Is CYPH profitable?
Cypherpunk Technologies Inc. (CYPH) reported a net loss of $56.9M for fiscal year 2025.
Dividend & Returns
What is CYPH's return on equity?
Cypherpunk Technologies Inc. (CYPH) has a return on equity (ROE) of 5.1%. This is below average, suggesting room for improvement.
What is Cypherpunk Technologies Inc.'s free cash flow?
Cypherpunk Technologies Inc. (CYPH) had negative free cash flow of $42.8M in fiscal year 2025, likely due to heavy capital investments.